Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 19 studies | 46% ± 19% | |
| peripheral blood | 19 studies | 46% ± 15% | |
| intestine | 11 studies | 44% ± 21% | |
| brain | 10 studies | 32% ± 8% | |
| kidney | 9 studies | 39% ± 16% | |
| eye | 8 studies | 34% ± 14% | |
| liver | 8 studies | 42% ± 24% | |
| lymph node | 6 studies | 49% ± 16% | |
| pancreas | 5 studies | 48% ± 19% | |
| bone marrow | 5 studies | 42% ± 18% | |
| uterus | 5 studies | 57% ± 21% | |
| breast | 4 studies | 56% ± 8% | |
| placenta | 3 studies | 68% ± 9% | |
| adrenal gland | 3 studies | 38% ± 16% | |
| esophagus | 3 studies | 56% ± 29% | |
| thymus | 3 studies | 60% ± 32% | |
| prostate | 3 studies | 56% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 14490.45 | 1445 / 1445 | 100% | 158.69 | 183 / 183 |
| liver | 100% | 7437.21 | 226 / 226 | 100% | 75.46 | 406 / 406 |
| ovary | 100% | 11374.77 | 180 / 180 | 100% | 135.85 | 430 / 430 |
| prostate | 100% | 9998.12 | 245 / 245 | 100% | 123.98 | 502 / 502 |
| stomach | 100% | 9286.00 | 359 / 359 | 100% | 136.33 | 286 / 286 |
| uterus | 100% | 11883.46 | 170 / 170 | 100% | 182.32 | 459 / 459 |
| lung | 100% | 10380.01 | 577 / 578 | 100% | 128.02 | 1155 / 1155 |
| intestine | 100% | 11439.31 | 966 / 966 | 100% | 135.67 | 526 / 527 |
| bladder | 100% | 11874.95 | 21 / 21 | 100% | 132.15 | 503 / 504 |
| skin | 100% | 20549.99 | 1809 / 1809 | 100% | 140.29 | 471 / 472 |
| breast | 100% | 14703.30 | 459 / 459 | 100% | 139.80 | 1115 / 1118 |
| thymus | 100% | 10677.92 | 653 / 653 | 100% | 123.02 | 603 / 605 |
| pancreas | 99% | 8529.32 | 326 / 328 | 100% | 97.62 | 178 / 178 |
| brain | 99% | 6066.83 | 2622 / 2642 | 100% | 101.52 | 705 / 705 |
| kidney | 100% | 8891.73 | 89 / 89 | 97% | 90.24 | 876 / 901 |
| adrenal gland | 100% | 9852.43 | 258 / 258 | 83% | 41.92 | 191 / 230 |
| adipose | 100% | 14831.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 12557.95 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 155.33 | 29 / 29 |
| muscle | 100% | 17867.13 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 9226.28 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 185.00 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 67.98 | 1 / 1 |
| heart | 96% | 7181.02 | 826 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 84.38 | 76 / 80 |
| peripheral blood | 92% | 12517.40 | 851 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043488 | Biological process | regulation of mRNA stability |
| GO_0141014 | Biological process | ribosome hibernation |
| GO_0030578 | Biological process | PML body organization |
| GO_0017148 | Biological process | negative regulation of translation |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0016020 | Cellular component | membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043228 | Cellular component | non-membrane-bounded organelle |
| GO_0005634 | Cellular component | nucleus |
| GO_0030371 | Molecular function | translation repressor activity |
| GO_0043022 | Molecular function | ribosome binding |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0061770 | Molecular function | translation elongation factor binding |
| GO_0032183 | Molecular function | SUMO binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0003730 | Molecular function | mRNA 3'-UTR binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SERBP1 |
| Protein name | SERPINE1 mRNA-binding protein 1 (PAI1 RNA-binding protein 1) (PAI-RBP1) (Plasminogen activator inhibitor 1 RNA-binding protein) |
| Synonyms | PAIRBP1 CGI-55 |
| Description | FUNCTION: Ribosome-binding protein that promotes ribosome hibernation, a process during which ribosomes are stabilized in an inactive state and preserved from proteasomal degradation . Acts via its association with EEF2/eEF2 factor, sequestering EEF2/eEF2 at the A-site of the ribosome and promoting ribosome stabilization and storage in an inactive state (By similarity). May also play a role in the regulation of mRNA stability: binds to the 3'-most 134 nt of the SERPINE1/PAI1 mRNA, a region which confers cyclic nucleotide regulation of message decay . Seems to play a role in PML-nuclear bodies formation . . |
| Accessions | Q8NC51 ENST00000370990.5 [Q8NC51-2] ENST00000361219.11 [Q8NC51-3] ENST00000370994.8 [Q8NC51-4] ENST00000370995.6 [Q8NC51-1] |